Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trifunctional purine biosynthetic protein adenosine-3 (GART) is a multi-domain, trifunctional enzyme that plays a pivotal role in the de novo purine nucleotide biosynthetic pathway. It catalyzes three non-sequential steps in this pathway: phosphoribosylamine-glycine ligase (GARS), phosphoribosylformylglycinamidine cyclo-ligase (AIRS), and phosphoribosylglycinamide formyltransferase (GART/GARFT). Because rapidly proliferating cancer cells exhibit a high demand for purine nucleotides to support DNA replication and RNA transcription, GART is frequently overexpressed in various malignancies, including breast cancer, lung cancer, glioma, and colorectal cancer. Consequently, GART has emerged as an attractive therapeutic target in oncology. Antifolate drugs, such as the approved agent pemetrexed and investigational inhibitors like lometrexol, pelitrexol (AG2037), and LY309887, target the formyltransferase domain of GART to disrupt purine synthesis, deplete cellular ATP/GTP pools, and induce cell cycle arrest and apoptosis. However, clinical development of selective GART inhibitors has historically been challenged by cumulative toxicities, such as myelosuppression and mucositis, which are often managed with folate supplementation.
Enzyme inhibition, antimetabolite activity, and disruption of de novo purine nucleotide biosynthesis
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trifunctional purine biosynthetic protein adenosine-3 (GART) (GART).